FIELD: veterinary medicine.
SUBSTANCE: nocodazole is administered subcutaneously in an amount which does not cause formation of a connective tissue capsule around the medicinal product, 10 injections per day in a daily dose of 11-200 mg/kg with an interval of 3-4 days, in the points located on the dorsal and ventral surfaces of the animal body.
EFFECT: method is highly effective for treatment of cystic and alveolar larval echinococcosis and other tissue parasitic diseases of laboratory animals.
1 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTHELMINTHIC AGENT | 1998 |
|
RU2153329C2 |
| ANTHELMINTIC AGENT | 2001 |
|
RU2195280C1 |
| METHOD FOR MODELING IMAGINAL ALVEOCOCCOSIS | 2006 |
|
RU2310923C1 |
| METHOD FOR PREVENTION OF LARVAL STAGE OF ECHINOCOCCOSIS ALVEOLARIS | 2016 |
|
RU2609858C1 |
| METHOD FOR ACTIVATION OF CESTODE ONCOSPHERES FOR LABORATORY DEVELOPMENTS OF ANTIGEN | 2020 |
|
RU2725248C1 |
| MEDICINAL AGENT BASED ON SYNTHETIC COPOLYMER OF VINYLPYRIDINE ROW FOR TREATING TISSUE HELMINTHIASIS | 2019 |
|
RU2727935C1 |
| 6-[4-(4-ALKYLPIPERAZINYL-1)PHENYLAMINO]-1,2,5-THIADIAZOLO[3,4- -H]QUINOLINES SHOWING ANTHELMINTIC ACTIVITY AT ALVEOLAR ECHINOCOCCOSIS AND HYMENOLEPIDOSIS | 1991 |
|
RU2021275C1 |
| METHOD OF IMMUNOTHERAPY FOR SECONDARY ALVEOLAR ECHINOCOCCOSIS | 2017 |
|
RU2674767C1 |
| METHOD FOR OBTAINING A PURE VIABLE CULTURE OF PROTOSCOLEXES ECHINOCOCCUS MULTILOCULARIS | 2017 |
|
RU2665781C1 |
| 4-[(BENZO-2,1,3-THIADIAZOLYL-4)-AMINO]-5,6,7,8-TETRAHYDROBEN-ZOTHIENO-[2,3-D]-PYRIMIDINE SHOWING ANTHELMINTIC ACTIVITY IN LARVAL ALVEOLAR ECHINOCOCCOSIS | 1997 |
|
RU2116309C1 |
